SEC Comment Letter 0000000000-26-004850 to Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW)
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: May 12, 2026 · CIK: 0001130598 · Accession: 0000000000-26-004850
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295727
Letter
May 12, 2026 Iain Dukes Chief Executive Officer Traws Pharma, Inc. 12 Penns Trail Newton, PA 18940 Re: Traws Pharma, Inc. Registration Statement on Form S-3 Filed May 8, 2026 File No. 333-295727 Dear Iain Dukes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Bardia Moayedi, Esq.
Show Raw Text
May 12, 2026 Iain Dukes Chief Executive Officer Traws Pharma, Inc. 12 Penns Trail Newton, PA 18940 Re: Traws Pharma, Inc. Registration Statement on Form S-3 Filed May 8, 2026 File No. 333-295727 Dear Iain Dukes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Bardia Moayedi, Esq.